Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,347 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Evaluation of national institute for health and care excellence guidance for ruptured abdominal aortic aneurysms by emulating a hypothetical target trial.
Eilenberg W, Waduud MA, Davies H, Bailey MA, Scott DJA, Wolf F, Sotir A, Lakowitsch S, Kaider A, Heinze G, Brostjan C, Domenig CM, Neumayer C. Eilenberg W, et al. Among authors: wolf f. Front Cardiovasc Med. 2023 Jul 28;10:1219744. doi: 10.3389/fcvm.2023.1219744. eCollection 2023. Front Cardiovasc Med. 2023. PMID: 37576114 Free PMC article.
Correction to: The Current Use of Drug-Eluting Balloons and Stents in Peripheral Arterial Disease: An Online Survey by the Cardiovascular and Interventional Radiological Society of Europe (CIRSE).
Morgan RA, Müller-Hülsbeck S, Fanelli F, Haage P, Hamady M, Loffroy R, O'Sullivan G, Wolf F, Slijepčević B. Morgan RA, et al. Among authors: wolf f. Cardiovasc Intervent Radiol. 2023 Dec;46(12):1773-1774. doi: 10.1007/s00270-023-03591-y. Cardiovasc Intervent Radiol. 2023. PMID: 37910260 Free PMC article. No abstract available.
Re-analysis of Old Data and New Outcomes Data Do Not Support a Link Between Paclitaxel Coated Balloons and Paclitaxel Eluting Stents and Mortality: These Devices Should be Used in PAD (Peripheral Arterial Disease) Treatment in Femoropopliteal Disease on the Basis of Their Published Efficacy.
Müller-Hülsbeck S, Fanelli F, Haage P, Hamady M, Loffroy R, O'Sullivan G, Wolf F, Morgan RA. Müller-Hülsbeck S, et al. Among authors: wolf f. Cardiovasc Intervent Radiol. 2023 Aug;46(8):977-980. doi: 10.1007/s00270-023-03507-w. Epub 2023 Jul 12. Cardiovasc Intervent Radiol. 2023. PMID: 37436438 No abstract available.
Endovascular stroke therapy outside core working hours in a nationwide stroke system.
Fandler-Höfler S, Mikšová D, Deutschmann H, Kneihsl M, Mutzenbach S, Killer-Oberpfalzer M, Gizewski ER, Knoflach M, Kiechl S, Sonnberger M, Vosko MR, Weber J, Hausegger KA, Serles W, Werner P, Staykov D, Sykora M, Lang W, Ferrari J, Enzinger C, Gattringer T; Austrian EVT Study Group. Fandler-Höfler S, et al. J Neurointerv Surg. 2023 Dec 21;15(e3):e402-e408. doi: 10.1136/jnis-2022-020044. J Neurointerv Surg. 2023. PMID: 36813552
The Current Use of Drug-Eluting Balloons and Stents in Peripheral Arterial Disease: An Online Survey by the Cardiovascular and Interventional Radiological Society of Europe (CIRSE).
Morgan RA, Müller-Hülsbeck S, Fanelli F, Haage P, Hamady M, Loffroy R, O'Sullivan G, Wolf F, Slijepčević B. Morgan RA, et al. Among authors: wolf f. Cardiovasc Intervent Radiol. 2023 Dec;46(12):1743-1747. doi: 10.1007/s00270-023-03562-3. Epub 2023 Sep 27. Cardiovasc Intervent Radiol. 2023. PMID: 37759088 Free PMC article.
1,347 results